Veeral Ajmera

Appearances

ACHIEVING MORE EQUITABLE ALLOCATION OF DONOR LIVER GRAFTS THROUGH BALANCING SURVIVAL AND MEDICAL URGENCY: A NOVEL MATHEMATICAL MODEL MONALISA 1.0
Date
May 6, 2023
BACKGROUND: Organ allocation based on the principles of urgency vs utility presents an ethical conundrum given the scarcity of liver grafts…
Speakers
Nicholas Syn
Wen Hui Lim
Cheng Han Ng
Darren Tan
Rebecca Wenling Zeng
Mark Muthiah
Daniel Huang
Eunice Tan
Karn Wijarnpreecha
Michael Tseng
Philip Vutien
Veeral Ajmera
Mary Rinella
Mazen Noureddin
Mohammad Shadab Siddiqui
Presenter
Jieling Xiao
VALIDATION OF THE AGA CLINICAL CARE PATHWAY AND NEW AASLD GUIDANCE FOR NONALCOHOLIC FATTY LIVER DISEASE IN A PROSPECTIVE COHORT OF PATIENTS WITH TYPE 2 DIABETES
Date
May 6, 2023
The rising prevalence of non-alcoholic fatty liver disease (NAFLD) will result in increased referrals to gastroenterology and hepatology units…
Presenter
Veeral Ajmera
Speakers
Vanessa Cervantes
Kaleb Tesfai
Ricki Bettencourt
Lisa Richards
Rohit Loomba
LEAN, OVERWEIGHT AND OBESE MASLD PATIENTS HAVE SIMILAR AMOUNTS OF FIBROSIS THAT IS ASSOCIATED WITH POLYGENIC RISK
Date
May 19, 2024
BACKGROUND AND AIMS: There is conflicting data on the risk of fibrosis and liver-related outcomes in patients with lean MASLD and the role of genetic testing in this population…
Presenter
Veeral Ajmera
Speakers
Kaleb Tesfai
Seema Singh
Egbert Madamba
Rohit Loomba
University of California San Diego
MASLD For the Non-Hepatologist
Date
May 18, 2024
RISK STRATIFICATION IN REFERRALS FOR MASLD: GI ASSESSMENT
Moderators
Sonal Kumar
Weill Cornell Medical College
Vincent Chen
University of Michigan Medical School
Speakers
Veeral Ajmera
Arpan Mohanty
Sujit Janardhan